Rigel Pharmaceuticals Inc
RIGL· Nasdaq
RIGLRigel Pharmaceuticals Inc
Released Aug 7, 2012, before the open
10-Q filed Aug 7, 2012, 38 days after period end · 0001104659-12-054905
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q2 2012 | Q2 2011 | Q2 2010 |
|---|---|---|---|
| Net Income | — | -$21.47M | $27.03M |
| EPS Diluted | -$0.35 | -$0.37 | $0.51 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Rigel Pharmaceuticals Inc · CIK 1034842 · Engraved from SEC EDGAR
ended Jun 30, 2012 · filed Aug 7, 2012 · 38 d after period end
4.3% from the close of Aug 6, 2012 to the close of Aug 7, 2012, the first after the release.
